|
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
This was associated with a vascular site-specific effect of Ikkα<sup>AA/AA</sup> knock-in on atherosclerosis: in the aortic root, Ikkα<sup>AA/AA</sup> knock-in decreased lesion size by 22.0 ± 7.7% (p < 0.01), reduced absolute lesional smooth muscle cell numbers and lowered pro-atherogenic MMP2.
|
31733453 |
2020 |
|
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
<i>Background</i>: The expression of matrix metalloproteinases 2/9 (MMP-2/9) has been implicated in arterial remodeling and inflammation in atherosclerosis.
|
30513758 |
2018 |
|
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Here, we report that bone morphogenetic protein 2 (BMP-2) leads to enrichment of CD44 and F-actin stress fiber and secretion of matrix metalloproteinases-2 (MMP-2) during hypoxia in vitro and following artificial hypoxia-induced atherosclerosis exacerbation in vivo.
|
29750899 |
2018 |
|
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Additionally, ginkgetin reduced the mRNA and protein expression of MMP-2 and MMP-9 in thoracic aortas of rats with atherosclerosis.
|
29579712 |
2018 |
|
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
<b>Conclusion:</b> RDN promoted atherosclerosis in apolipoprotein E-deficient mice infused with angiotensin II associated with upregulation of MMP-2.
|
28450836 |
2017 |
|
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Our data have showed a large increase in the enzyme MMP-2 and 9 in the urine of CAS and A patients in comparison with healthy controls and indicated this method as an easy marker for the monitoring of the development of atherosclerosis.
|
28500763 |
2017 |
|
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
These findings suggest that FXa/FIIa inhibition limits aortic aneurysm and atherosclerosis severity due to down-regulation of vascular PAR-2-mediated Smad2/3 signalling and MMP2 expression.
|
28220880 |
2017 |
|
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
Systematic (circulated in plasma) neutrophil gelatinase come from multiple sources; it may be synthesized in the liver, secreted from activated neutrophils or macrophages, or derive from atherosclerosis or inflammatory endothelial cells [17].
|
27708207 |
2016 |
|
Atherosclerosis
|
0.300 |
AlteredExpression
|
disease |
BEFREE |
Cholestin reduces TNF-α-stimulated MMP-2 and MMP-9 expression as well as downregulating NF-κB activation and intracellular ROS formation in HASMCs, supporting the notion that the natural compound Cholestin may have potential application in clinical atherosclerosis disease.
|
22060290 |
2011 |
|
Atherosclerosis
|
0.300 |
GeneticVariation
|
disease |
BEFREE |
MMP2 genetic variation is associated with measures of fibrous cap thickness: The Atherosclerosis Risk in Communities Carotid MRI Study.
|
20064641 |
2010 |
|
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
LHGDN |
Serum matrix metalloproteinase-2 and increased oxidative stress are associated with carotid atherosclerosis in hemodialyzed patients.
|
16510149 |
2007 |
|
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
RGD |
Our results suggest that the expression of CD40 and CD40L in the blood cells and the activities of MMP-2 and MMP-9 in plasma were higher in As group than those in Normal group, indicating that they may contribute to the formation of atherosclerosis.
|
16317521 |
2006 |
|
Atherosclerosis
|
0.300 |
Biomarker
|
disease |
BEFREE |
However, since these cell lines did not show a fully malignant phenotype, we concluded that, in addition to the degradation of extracellular matrix macromolecules, including basement membrane components by MMP-2, -3, and/or -9, some additional factors must be involved for the malignancy of fully transformed cells and that these immortalized human aortic SMC, which share many characteristics with normal SMC, will prove useful to study the role(s) of metalloproteinases in atherosclerosis.
|
1333771 |
1992 |